You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
長江生科(00775.HK)夥長和(00001.HK)投資癌症早期檢測公司Pharus
長江生命科技(00775.HK)宣佈,聯同長和(00001.HK)投資從事癌症早期檢測分子診斷的研究、開發及商業化業務的Pharus。 長江生科旗下長江生命科技投資者與長和全資附屬長和投資者於今日(25日)與Pharus訂立認購協議,公司及長和將各自認購Pharus 550萬股A2系列優先股,代價各爲550萬美元。 交易完成後,長江生命科技及長和預期將各自持有Pharus已發行股本總額約18.33%。 長江生科表示,預期是次共同投資所提供的投資機遇,可與公司現有醫藥研發業務營運產生協同效應,並可能獲得具吸引力的回報及資本增值。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account